The importance of cysteine proteases in parasites, compounded with the lack of redundancy compared to their mammalian hosts makes proteases attractive targets for the development of new therapeutic agents. The binding mode of K11002 to cruzain, the major cysteine protease of Trypanosoma cruzi was used in the design of conformationally constrained inhibitors. Vinyl sulfonecontaining macrocycles were synthesized via olefin ring-closing metathesis and evaluated against cruzain and the closely related cysteine protease, rhodesain.Trypanosomes are parasitic protozoa responsible for several neglected diseases of global health importance including Chagas' disease and sleeping sickness. Chagas' disease, or American trypanosomiasis, is a chronic infection caused by the parasite, Trypanosoma cruzi, and is the leading cause of heart failure in many Latin American countries. 1 T. cruzi is transmitted to humans through the bite of the triatomine bug or by transfusion of infected blood. The overall prevalence of human infection is estimated at 16 to 18 million cases with 13,000 deaths reported each year. 2 Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense are the pathogenic agents of human African trypanosomiasis, or sleeping sickness. These parasites live extracellularly in blood and tissue fluids of the mammalian host and are transmitted by the bite of tsetse flies. The disease is endemic in certain regions of sub-Saharan Africa, covering about 50 million people in 36 countries. It is estimated that 50,000 to 70,000 people are currently infected; if left untreated, the disease in humans is fatal. 3 Current drug therapy for trypanosomal diseases is not always effective and is often hampered by severe side effects. 4 Thus, the identification of novel targets for trypanocidal agents is needed. One such target is the major cysteine protease of the parasitic organisms, which includes cruzain 5 in T. cruzi and rhodesain 6 in T. brucei rhodesiense. Both enzymes are clan CA proteases, share 70% similarity in primary structure, and are involved in critical roles in parasite survival, such as replication, penetration into host cells, nutrition at the expense of the host, and immunoevasion. 7 Selective inhibitors of cruzain have been demonstrated to cure T. cruzi infection both in cell culture screens and in mouse models of Chagas' disease. 8 In aCorrespondence to: William R. Roush. 1 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript recent report, a cruzain inhibitor was also found to be effective in treat...